Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP493142.RAOWHUrScQstVKe2VosNApBOckN3oqGq1vH1ZM9Tdq_2s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP493142.RAOWHUrScQstVKe2VosNApBOckN3oqGq1vH1ZM9Tdq_2s130_assertion type Assertion NP493142.RAOWHUrScQstVKe2VosNApBOckN3oqGq1vH1ZM9Tdq_2s130_head.
- NP493142.RAOWHUrScQstVKe2VosNApBOckN3oqGq1vH1ZM9Tdq_2s130_assertion wasGeneratedBy ECO_0000203 NP493142.RAOWHUrScQstVKe2VosNApBOckN3oqGq1vH1ZM9Tdq_2s130_provenance.
- NP493142.RAOWHUrScQstVKe2VosNApBOckN3oqGq1vH1ZM9Tdq_2s130_assertion wasDerivedFrom befree-20150227 NP493142.RAOWHUrScQstVKe2VosNApBOckN3oqGq1vH1ZM9Tdq_2s130_provenance.
- NP493142.RAOWHUrScQstVKe2VosNApBOckN3oqGq1vH1ZM9Tdq_2s130_assertion SIO_000772 9742914 NP493142.RAOWHUrScQstVKe2VosNApBOckN3oqGq1vH1ZM9Tdq_2s130_provenance.
- NP493142.RAOWHUrScQstVKe2VosNApBOckN3oqGq1vH1ZM9Tdq_2s130_assertion evidence source_evidence_literature NP493142.RAOWHUrScQstVKe2VosNApBOckN3oqGq1vH1ZM9Tdq_2s130_provenance.
- NP493142.RAOWHUrScQstVKe2VosNApBOckN3oqGq1vH1ZM9Tdq_2s130_assertion description "[Treatment with high-dose bolus IL-2 mediates complete cancer regression in approximately 8% of patients with metastatic renal cancer and melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493142.RAOWHUrScQstVKe2VosNApBOckN3oqGq1vH1ZM9Tdq_2s130_provenance.